Effects of Moxaverine and Placebo on Ocular Blood Flow

Launched by MEDICAL UNIVERSITY OF VIENNA · Jul 2, 2008

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Men and women aged between 18 and 35 years, nonsmokers
• • Body mass index between 15th and 85th percentile
• • Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
• • Normal laboratory values unless the investigator considers an abnormality to be clinically irrelevant
• • Normal ophthalmic findings, ametropy \< 3 dpt.
• Exclusion Criteria:
• • Regular use of medication, abuse of alcoholic beverages or drugs, participation in a clinical trial in the 3 weeks preceding the study
• • Treatment in the previous 3 weeks with any drug
• • Symptoms of a clinically relevant illness in the 3 weeks before the first study day
• • History or presence of gastrointestinal, liver or kidney disease, or other conditions known to interfere with distribution, metabolism or excretion of study drugs
• • Blood donation during the previous 3 weeks
• • Ametropy \>= 3 dpt
• • Acute gastric bleeding, massive cerebral hemorrhage related to stroke
• • Women: pregnancy or lactation

Trial Officials